October 2002

San Fran Bay Hospitals Jointly Fund MT Training

CEO SUMMARY: Laboratory administrators in 15 Bay-area hospitals created their own plan to expand the available pool of trained med techs. Using a detailed analysis of the demographics of the problem, along with a financial analysis of non-action, they convinced CEOs of 15 hospitals to invest $1.5 million in a five-year training program. EDITOR’S NOTE: […]

To access this post, you must purchase The Dark Report.

San Fran Bay Hospitals Jointly Fund MT Training Read More »

ARUP & Mayo Respond To New Market Cycle

The Dark Report / Robert Michel

CEO SUMMARY: Since the beginning of 2002, several important events changed the competitive status quo among the nation’s leading providers of hospital send-out testing. As part of its ongoing assessment of this market segment, THE DARK REPORT provides strategic management insights from executives at ARUP Laboratories and Mayo Medical Laboratories. IN THE HOSPITAL SEND-OUT marketplace,

To access this post, you must purchase The Dark Report.

ARUP & Mayo Respond To New Market Cycle Read More »

Quest & LabCorp Encounter Different Business Hurdles

The Dark Report / Robert Michel

IT’S BEEN TOUGH SLEDDING in recent months for both Laboratory Corporation of America and Quest Diagnostics Incorporated. THE DARK REPORT believes there may be significance in these developments. Both national labs find themselves confronted with unexpected obstacles. Though different, each case may be evidence of subtle changes in the competitive marketplace for physicians’ office testing.

To access this post, you must purchase The Dark Report.

Quest & LabCorp Encounter Different Business Hurdles Read More »

“October 7, 2002 Intelligence: Late Breaking Lab News”

Late Breaking Lab News / Robert Michel

Without much fanfare or notice, Liposcience Inc. of Raleigh, North Carolina tested the waters for an initial public offering (IPO) last month. It found market conditions unfavorable for its proposed offering of $92 million and deferred its IPO. Liposcience, with annual revenues of $18.5 million, markets a cardiovascular test built upon nuclear magnetic resonance (NMR)

To access this post, you must purchase The Dark Report.

“October 7, 2002 Intelligence: Late Breaking Lab News” Read More »